Technology
Health
Biotechnology

Alpine Immune Sciences

$5.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.41 (7.40%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ALPN and other stocks, options, ETFs, and crypto commission-free!

About

Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. Read More It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.

Employees
48
Headquarters
Seattle, Washington
Founded
2015
Market Cap
110.44M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
16.23K
High Today
$5.95
Low Today
$5.55
Open Price
$5.55
Volume
3.27K
52 Week High
$10.57
52 Week Low
$3.66

Collections

Technology
Health
Biotechnology
Pharmaceutical
Cancer Prevention
2015 IPO
US
North America

News

NasdaqMay 6

Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to Decline

The market expects Alpine Immune Sciences (ALPN) to deliver a year-over-year decline in earnings on lower revenues when i t report s results for the quarter ended March 2019. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

12
Simply Wall StApr 24

Need To Know: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Insiders Have Been Buying Shares

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Alpine Immune Sciences, Inc. (NASDAQ:ALPN), you may well want to know whether insiders have been buying or selling. What Is Insider Selling? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, rules govern i...

27
Yahoo FinanceApr 24

Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares?

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN). What Is Insider Selling? Scroll to continue with content Ad It is perfectly legal for company insiders, including board members, to buy and sell stock in a co...

15

Earnings

-$0.88
-$0.71
-$0.54
-$0.37
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.69 per share
Actual
-$0.70 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.